Experimental SSM-CVB3 infection in macaques

Experimental and Molecular Pathology

Volumn 92, Issue 1, 2012, Pages 131-139

  Han, Tiesuo ^a   He, Wenqi ^a   Song, Deguang ^a   Zhao, Kui ^a   Wu, Chenchen ^a   Gao, Feng ^a   Lu, Huijun ^a   Gai, Xianying ^a   Wang, Xinrui ^a   Li, Fei ^a   Ji, Cuicui ^a   Lin, Xijuan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Hepatic damage; Macaque model; Pathogenicity; Renal damage; SSM CVB3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CREATINE KINASE; CREATINE KINASE MB; DECAY ACCELERATING FACTOR; MESSENGER RNA;

ALBUMINURIA; ANIMAL CELL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; DIARRHEA; ERYTHROCYTE COUNT; FEMALE; FEVER; HEART DISEASE; HEMATOLOGY; HEMATURIA; HISTOPATHOLOGY; INOCULATION; KIDNEY DISEASE; LEUKOCYTE COUNT; LIVER DISEASE; MACACA; NONHUMAN; PATHOGENESIS; RISK FACTOR; SICHUAN SNUB NOSED MONKEY COXSACKIE VIRUS INFECTION; SYMPTOMATOLOGY; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ALBUMINURIA; ANEMIA; ANIMALS; ANTIGENS, CD55; CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS INFECTIONS; DIARRHEA; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; FEMALE; HEMATURIA; HUMANS; MACACA; MONKEY DISEASES; RECEPTORS, VIRUS; RNA, VIRAL; VERO CELLS; VIRAL LOAD;

ADENOVIRIDAE; COXSACKIEVIRUS; MACACA;

EID: 83055163715     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.10.008     Document Type: Article

References (52)

1. Abzug M.J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatric Infectious Disease Journal 2001, 20:758-763.
2. Abzug M.J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatric Infectious Disease Journal 2001, 20:758-763.
3. Abzug M.J., Keyserling H.L., Lee M.L., Levin M.I., Rotbart H.A. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clinical Infectious Diseases 1995, 20:1021-1026.
4. Arena U., Vizzutti F., Corti G., Ambu S., Stasi C., Bresci S. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008, 47:380-384.
5. Bankamp B., Hodge G., McChesney M.B., Bellini W.J., Rota P.A. Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 2008, 373:39-50.
6. Begovac J., Puntaric B., Borcic D., Barsic B., Zrinscak J., Beus I., Presecki V. Mononucleosis-like syndrome associated with a multisystem Coxsackie virus type B3 infection in adolescent. European Journal of Pediatrics 1988, 147:426-427.
7. Bergelson J.M., Mohanty J.G., Crowell R.L., St John N.F., Lublin D.M., Finberg R.W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology 1995, 69:1903-1906.
8. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
9. Bryant P.A., Tingay D., Dargaville P.A., Starr M., Curtis N. Neonatal coxsackie B virus infection: a treatable disease?. European Journal of Pediatrics 2004, 163:223-228.
10. Carson S.D. Receptor for the group B coxsackieviruses and adenoviruses: CAR. Reviews in Medical Virology 2001, 11:219-226.
11. Cheng L.L., Ng P.C., Chan P.K., Wong H.L., Cheng F.W., Tang J.W. Probable intrafamilial transmission of Coxsackievirus B3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 2006, 118:929-933.
12. Delic D., Nesic Z., Prostran M., Simonovic J., Jankovic S. Anicteric hepatitis in an adult associated with coxsackie B4 virus infection. Infection 2006, 34:236-237.
13. Fairweather D., Rose N. Models of coxsackievirus-B3-induced myocarditis: recent advances. Drug Discovery Today Disease Models 2004, 1:381-386.
14. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., Rose N.R. From infection to autoimmunity. Journal of Autoimmunity 2001, 16:175-186.
15. Fechner H., Haack A., Wang H., Wang X., Eizema K., Pauschinger M., Schoemaker R., Veghel R., Houtsmuller A., Schultheiss H.P., et al. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Therapy 1999, 6:1520-1535.
16. Franchini G. Modeling immune intervention strategies for HIV-1 infection of humans in the macaque model. Clinical and Applied Immunology Reviews 2003, 3:289-306.
17. Gauntt C., Huber S. Coxsackievirus experimental heart diseases. Frontiers in Bioscience 2003, 8:23-35.
18. Gay R.T., Belisle S., Beck M.A., Meydani S.N. An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13825-13830.
19. Hara M., Hagiwara A., Yoneyama T., Saito Y., Shimojo H. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin. Microbiology and Immunology 1983, 27:1057-1065.
20. He W., Lu H., Song D., Zhao K., Gai X., Wang X., Chen Q., Gao F. The evidence of Coxsackievirus B3 induced myocarditis as the cause of death in a Sichuan snub-nosed monkey (Rhinopithecus roxellana). Journal of Medical Primatology 2009, 38:192-198.
21. Hoshino T., Kawai C., Tokuda M. Experimental coxsackie B viral myocarditis in cynomolgus monkeys. Japanese Circulation Journal 1983, 47:59-66.
22. Huber S., Ramsingh A.I. Coxsackievirus-induced pancreatitis. Viral Immunology 2004, 17:358-369.
23. Jarcuska P., Orolin M., Kovacova A., Hancova M. Prognostic importance of the monitoring of selected parameters in liver cirrhosis. Bratislavske Lekarske Listy 2003, 104:400-404.
24. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100.
25. Kelly M.E., Soike K., Ahmed K., Iatropoulos M.J. Coxsackievirus in an infant chimpanzee. Journal of Medical Primatology 1978, 7:119-121.
26. Kemp M., Donovan J., Higham H., Hooper J. Biochemical markers of myocardial injury. British Journal of Anaesthesia 2004, 93:63-73.
27. Kitano M., Itoh Y., Kodama M., Ishigaki H., Nakayama M., Nagata T., Ishida H., Tsuchiya H., Torii R., Baba K., et al. Establishment of a cynomolgus macaque model of influenza B virus infection. Virology 2010, 407:178-184.
28. Klingel K., Schnorr J.J., Sauter M., Szalay G., Kandolf R. β2-microglobulin-associated regulation of interferon-and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. American Journal of Pathology 2002, 162:1709-1720.
29. Lundgren D.L., Hobbs C.H., Clapper W.E. Experimental infection of beagle dogs with Coxsackievirus type B1. American Journal of Veterinary Research 1971, 32:609-613.
30. Magnani J.W., Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 2006, 113:876-890.
31. Maisch B., Ristic A.D., Hufnagel G., Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovascular Pathology 2002, 11:112-122.
32. Marian A.J., Nambi V. Biomarkers of cardiac disease. Expert Review of Molecular Diagnostics 2004, 4:805-820.
33. Martino T.A., Petric M., Weingartl H., Bergelson J.M., Opavsky M.A., Richardson C.D., Modlin J.F., Finberg R.W., Kain K.C., Willis N., et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000, 271:99-108.
34. Mazze R.I., Callan C.M., Galvez S.T., Delgado-Herrera L., Mayer D.B. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesthesia and Analgesia 2000, 90:683-688.
35. Mena I., Fischer C., Gebhard J.R., Perry C.M., Harkins S., Whitton J.L. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 2000, 271:276-288.
36. Mena I., Fischer C., Gebhard J.R., Perry C.M., Harkins S., Whitton J.L. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 2000, 271:276-288.
37. Milstone A.M., Petrella J., Sanchez M.D., Mahmud M., Whitbeck J.C., Bergelson J.M. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. Journal of Virology 2005, 79:655-660.
38. Miyagi J., Tsuhako K., Kinjo T., Iwamasa T., Kamada Y., Kinju T., Koyanagi Y. Coxsackievirus B4 myocarditis in an orangutan. Veterinary Pathology 1999, 36:452-456.
39. Moridani M.Y., Bromberg I.L. Lipase and pancreatic amylase versus total amylase as biomarkers of pancreatitis: an analytical investigation. Clinical Biochemistry 2003, 36:31-33.
40. Page Y., Serrange C., Revillard J.P., Traeger J., Denoyel J. Letter: coxsackie B virus infections in kidney transplantation. La Nouvelle Presse Médicale 1976, 5:1587-1588.
41. Pasch A., Frey F.J. Coxsackie B viruses and the kidney-a neglected topic. Nephrology, Dialysis, Transplantation 2006, 21:1184-1187.
42. Reetoo K.N., Osman S.A., Illavia S.J., Cameron-Wilson C.L., Banatvala J.E., Muir P. Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. Journal of General Virology 2000, 81:2755-2762.
43. Saraste A., Arola A., Vuorinen T., Kytö V., Kallajoki M., Pulkki K. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovascular Pathology 2003, 12:255-262.
44. Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. Journal of Virology 1995, 69:3873-3877.
45. Sharpe S., Beer B., Hall G., Dennis M., Norley S., Cranage M. Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assays. Journal of Immunological Methods 2001, 258:137-140.
46. Shaw C.A., Holland P.C., Sinnreich M., Allen C., Sollerbrant K., Karpati G., Nalbantoglu J. Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. BMC Cell Biology 2004, 5:42.
47. Smith G.L., Shlipak M.G., Havranek E.P., Foody J.M., Masoudi F.A., Rathore S.S. Serum urea nitrogen, creatinine, and estimators of renal function. Archives of Internal Medicine 2006, 166:1134-1142.
48. Tang J.W., Bendig J.W., Ossuetta I. Vertical transmission of human echovirus 11 at the time of Bornholm disease in late pregnancy. Pediatric Infectious Disease Journal 2005, 24:88-89.
49. Tomko R.P., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3352-3356.
50. Wang S.M., Liu C.C., Yang Y.J., Yang H.B., Lin C.H., Wang J.R. Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. Journal of Infection 1998, 37:270-273.
51. Weaver V.M., Lee B.K., Ahn K.D., Lee G.S., Todd A.C., Stewart W.F. Associations of lead biomarkers with renal function in Korean lead workers. Occupational and Environmental Medicine 2003, 60:551-562.
52. Yoon J.W., London W.T., Curfman B.L., Brown R.L., Notkins A.L. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986, 35:712-716.